Longitudinal tau PET in ageing and Alzheimer’s disease

Jack, Clifford R, Wiste, Heather J, Schwarz, Christopher G, Lowe, Val J, Senjem, Matthew L, Vemuri, Prashanthi, Weigand, Stephen D, Therneau, Terry M, Knopman, Dave S, Gunter, Jeffrey L, Jones, David T, Graff-Radford, Jonathan, Kantarci, Kejal, Roberts, Rosebud O, Mielke, Michelle M, Machulda, Mary M, Petersen, Ronald C·2018·Brain

DOI 10.1093/brain/awy059

Cited by (442)

Items 301–400 of 442

Developing a novel reference region for [18F]PI-2620-PET imaging to facilitate the assessment of 4-repeat tauopathies
Lukas K. Frontzkowski, Johannes S. Gnörich, Mattes Groß, Amir Dehsarvi, Sebastian Niclas Roemer, Carla Palleis, Sabrina Katzdobler, Anna Dewenter, Anna Steward, Davina Biel et al. · 2025 · European Journal of Nuclear Medicine and Molecular Imaging
petBrain: a new pipeline for amyloid, Tau tangles and neurodegeneration quantification using PET and MRI
Pierrick Coupé, Boris Mansencal, Floréal Morandat, Sergio Morell-Ortega, Nicolas Villain, José V. Manjón, Vincent Planche · 2025 · Alzheimer s Research & Therapy
The intrinsic connectivity between the default mode and dorsal attention networks is an independent fMRI biomarker of Alzheimer's disease pathology burden
Diego Lombardo, Christian F. Beckmann · 2025 · NeuroImage
CSF glucose tracks regional tau progression based on Alzheimer's disease risk factors
Colleen Pappas, B. Klinedinst, Scott T. Le, Qian Wang, Brittany A. Larsen, K. McLimans, S. Lockhart, Karin Allenspach‐Jorn, J. Mochel, A. Willette · 2020 · Alzheimer's & Dementia
Association of Performance on the Financial Capacity Instrument–Short Form With Brain Amyloid Load and Cortical Thickness in Older Adults
Maria E. Vassilaki, Jeremiah A. Aakre, Walter K. Kremers, Michelle M. Mielke, Yonas E. Geda, Mary M. Machulda, David S. Knopman, Prashanthi Vemuri, Val J. Lowe, Clifford R. Jack et al. · 2022 · Neurology Clinical Practice
Longitudinal flortaucipir ([18F]AV-1451) PET imaging in primary progressive apraxia of speech
Rene L. Utianski, Peter R. Martin, Hugo Botha, Christopher G. Schwarz, Joseph R. Duffy, Ronald Carl Petersen, David S. Knopman, Heather M. Clark, Alissa M. Butts, Mary M. Machulda et al. · 2019 · Cortex
Multimodal and longitudinal characterization of distinct tau and atrophy clusters in Alzheimer’s disease spectrum
Boris‐Stephan Rauchmann, Ersin Ersözlü, Dorothea Luedecke, Nicolai Franzmeier, Robert Perneczky · 2025 · Scientific Reports
Air pollution as a key risk factor for alzheimer’s disease: A comprehensive review
Xiaojing Zhu, Chen Guo, Yuanxun Zhang, Yongjie Wei · 2025 · Environmental Technology & Innovation
Structurally and Morphologically Distinct Pathological Tau Assemblies Differentially Affect GVB Accumulation
Marta Jorge‐Oliva, Jan R.T. van Weering, Wiep Scheper · 2023 · International Journal of Molecular Sciences
Differential Synaptic Loss in β‐Amyloid Positive Versus β‐Amyloid Negative Corticobasal Syndrome
Negin Holland, George Savulich, Peter Simon Jones, David J. Whiteside, Duncan Street, Peter Swann, Michelle Naessens, Maura Malpetti, Young T. Hong, Tim D. Fryer et al. · 2024 · Movement Disorders
Complex relationships of socioeconomic status with vascular and Alzheimer’s pathways on cognition
Dror Shir, Jonathan Graff‐Radford, Angela J. Fought, Timothy G. Lesnick, Scott A. Przybelski, Maria E. Vassilaki, Val J. Lowe, David S. Knopman, Mary M. Machulda, Ronald Carl Petersen et al. · 2024 · NeuroImage Clinical
Novel hyperbranched rolling circle amplification-driven aptasensor for ultrasensitive and multiplex biomarkers detection of Alzheimer's disease
Jiajun Zhong, Qiwei Wang, Qianyi Li, Sijing Cui, Keyi Chen, Tongxu Gu, Shijun Li, Pengli Bai · 2025 · Sensors and Actuators B Chemical
CSF phosphorylated tau as an indicator of subsequent tau accumulation
Petrice M. Cogswell, Heather J. Wiste, Michelle M. Mielke, Christopher G. Schwarz, Stephen D. Weigand, Val J. Lowe, Terry M. Therneau, David S. Knopman, Jonathan Graff‐Radford, Prashanthi Vemuri et al. · 2022 · Neurobiology of Aging
Characterization of Altered Molecular Pathways in the Entorhinal Cortex of Alzheimer’s Disease Patients and In Silico Prediction of Potential Repurposable Drugs
Paolo Fagone, Katia Mangano, Gabriella Martino, Maria Catena Ausilia Quattropani, Manuela Pennisi, Rita Bella, Francesco Fisicaro, Ferdinando Nicoletti, Maria Cristina Petralia · 2022 · Genes
Contribution of Alzheimer's disease pathology to biological and clinical progression: A longitudinal study across two cohorts
Wei Zhang, Hui-Fu Wang, Kevin Kuo, Linbo Wang, Yuzhu Li, Jin‐Tai Yu, Jianfeng Feng, Wei Cheng · 2023 · Alzheimer s & Dementia
Isolated, Subtle Neurological Abnormalities in Mild Cognitive Impairment Types
Cecilia Camarda, Rosolino Camarda, Carmela Pipia, Delia Maria Azzarello, Emanuele Grassedonio, Gianluca Sottile, Giovanna Cilluffo, Paola Torelli · 2019 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
Amyloid‐β but not tau accumulation is strongly associated with longitudinal cognitive decline
Wenwen Wang, Jiani Huang, Shuangjie Qian, Yi Zheng, Xinyue Yu, Tao Jiang, Ruixue Ai, Jialong Hou, Enzi Ma, Jinlai Cai et al. · 2024 · CNS Neuroscience & Therapeutics
Amyloid-β and tau deposition in traumatic brain injury: a study of Vietnam War veterans
Hannah de Bruin, Colin Groot, Suzie Kamps, Everard G.B. Vijverberg, Anna Steward, Amir Dehsarvi, Yolande A.L. Pijnenburg, Rik Ossenkoppele, Nicolai Franzmeier · 2024 · Brain Communications
Establishing tau-PET cut-points for cognitive diagnosis with 18F-PI-2620 in a multi-ethnoracial cohort
Victoria R. Tennant, Koral V Wheeler, Noelle N. Lee, Jamie A. Terner, Maxwell W Hand, Suchita Ganesan, Patrick Walsh, Aisha Greene, Tyler Berkness, Tiantian Lei et al. · 2025 · Imaging Neuroscience
Association between FDG- and TSPO-PET signals across human and animal studies investigating neurodegenerative conditions: a systematic review
Luiza Santos Machado, Pedro Rodrigues Vidor, Lavínia Perquim, Christian Limberger, Leonardo Machado, Andréia Silva da Rocha, Carolina Soares, Nesrine Rahmouni, Wagner Scheeren Brum, Bruna Bellaver et al. · 2025 · Molecular Psychiatry
Enhancing Feature Selection for Imbalanced Alzheimer’s Disease Brain MRI Images by Random Forest
Xibin Wang, Qiong Zhou, Hui Li, Mei Chen · 2023 · Applied Sciences
Local molecular and connectomic contributions of tau-related neurodegeneration
Fardin Nabizadeh, Alzheimer’s Disease Neuroimaging Initiative, Michael Walter Weiner, Paul Aisen, Ronald Carl Petersen, Clifford R. Jack, William Jagust, John Q. Trojanowski, Arthur W. Toga, Laurel A. Beckett et al. · 2024 · GeroScience
White matter hyperintensities and TDP‐43 pathology in Alzheimer's disease
Arenn F. Carlos, Stephen D. Weigand, Nha Trang Thu Pham, Ronald Carl Petersen, Clifford R. Jack, Dennis W. Dickson, Jennifer Louise Whitwell, Keith A. Josephs · 2025 · Alzheimer s & Dementia
Affection of Motor Network Regions by Tau Pathology Across the Alzheimer's Disease Spectrum
Gérard N. Bischof, Elena Jaeger, Kathrin Giehl, Merle C. Hoenig, Alzheimer’s Disease Neuroimaging Initiative, Peter H. Weiss, Alexander E. Drzezga · 2023 · eNeuro
Investigating the feasibility of 18F‐flortaucipir PET imaging in the antemortem diagnosis of primary age‐related tauopathy (PART): An observational imaging‐pathological study
Anna Lavrova, Ryota Satoh, Nha Trang Thu Pham, Aivi T. Nguyen, Clifford R. Jack, Ronald Carl Petersen, Reichard R. Ross, Dennis W. Dickson, Val J. Lowe, Jennifer Louise Whitwell et al. · 2024 · Alzheimer s & Dementia
Neuroimaging and clinical characteristics of cognitive migration in community-dwelling older adults
Tuğçe Duran, James R. Bateman, Benjamin J. Williams, Mark Andrew Espeland, Timothy M. Hughes, Stephanie E. Okonmah‐Obazee, Melissa M. Rundle, Suzanne Craft, Samuel Neal Lockhart · 2022 · NeuroImage Clinical
The Amyloid Precursor Protein: More than Just Amyloid- Beta
Stefan D. Jevtic, John Provias · 2019 · Journal of Neurology and Experimental Neuroscience
Dynamic Aphasia as a Variant of Frontotemporal Dementia
Adithya Chandregowda, Heather M. Clark, Joseph R. Duffy, Mary M. Machulda, Val J. Lowe, Jennifer Louise Whitwell, Keith A. Josephs · 2021 · Cognitive and Behavioral Neurology
Calibration of Biophysical Models for tau-Protein Spreading in Alzheimer's Disease from PET-MRI
Klaudius Scheufele, Shashank Subramanian, George Biros · 2020 · arXiv (Cornell University)
Evaluation of partial volume correction and analysis of longitudinal [18F]GTP1 tau PET imaging in Alzheimer's disease using linear mixed-effects models
Sandra M. Sanabria Bohorquez, Suzanne L. Baker, Paul T. Manser, Mattéo Tonietto, Christopher Galli, Kristin R. Wildsmith, Yixuan Zou, Geoffrey A. Kerchner, Robby M. Weimer, Edmond Teng · 2024 · Frontiers in Neuroimaging
Continuum of Core 1 biomarkers in preclinical Alzheimer’s disease
Leonardino A. Digma, Christina B. Young, Joseph R. Winer, Karly Alex Cody, Kyan Younes, Jintao Sheng, Philip S. Insel, Robert A. Rissman, Reisa Anne Sperling, Elizabeth C. Mormino · 2026 · Alzheimer s Research & Therapy
APOE ɛ4 carriership determines a faster plasma p‐tau217 progression in Aβ‐positive individuals
Marcel S. Woo, Arthur C. Macedo, Seyyed Ali Hosseini, Joseph Therriault, Yi‐Ting Wang, Nesrine Rahmouni, Étienne Aumont, Stijn Servaes, Cécile Tissot, Jaime Fernández Arias et al. · 2025 · Alzheimer s & Dementia
Longitudinal monitoring of tau aggregation in progressive supranuclear palsy with [ 18 F]PI‐2620 PET
Johannes S. Gnörich, Julia Kusche‐Palenga, Carla Palleis, Antonia Neubauer, Lukas K. Frontzkowski, Alexander Jäck, Agnes Kling, Theresa Bauer, Hannah Eyob, Katharina Probst et al. · 2026 · Alzheimer s & Dementia
Aberrant excitatory neuronal ERBB4 promotes Alzheimer’s disease pathology
Se Young Lee, Eunseok Park, Ha-Eun Lee, Seongbin Kim, Yeji Yeo, Juwon Park, Young-Jin Choi, Kiheon Lee, Ki‐Jun Yoon, Sanghoon Park et al. · 2026 · Nature
The Role of Clinical Trials in Preclinical Alzheimer's Disease Drug Development Programs
Jeffrey L. Cummings · 2020 · The Journal of Prevention of Alzheimer s Disease
Bibliometric review on biomarkers for Alzheimer’s disease between 2000 and 2023
Xiaojie Yang, Huiling Qu · 2023 · Medicine
Generating PET scan patterns in Alzheimer’s by a mathematical model
Chaeyoung Lee, Avner Friedman · 2024 · PLoS ONE
Delayed primacy recall in AVLT is associated with medial temporal tau PET burden in cognitively unimpaired adults
Ainara Jauregi Zinkunegi, Tobey J. Betthauser, Cynthia M. Carlsson, Barbara B. Bendlin, Ozioma C. Okonkwo, Nathaniel A. Chin, Sanjay Asthana, Rebecca E. Langhough, Sterling C. Johnson, Kimberly Diggle Mueller et al. · 2025 · Cortex
Longitudinal flortaucipir ([18F]AV-1451) PET uptake in semantic dementia
Rene L. Utianski, Hugo Botha, Jennifer Louise Whitwell, Peter R. Martin, Christopher G. Schwarz, Joseph R. Duffy, Heather M. Clark, Anthony J. Spychalla, Matthew L. Senjem, Ronald Carl Petersen et al. · 2020 · Neurobiology of Aging
Elevated Tau PET Signal Depends on Abnormal Amyloid Levels and Correlates with Cognitive Impairment in Elderly Persons without Dementia
Ruiqi Zhang, Alzheimer’s Disease Neuroimaging Initiative, Shi-Dong Chen, Xue‐Ning Shen, Yu‐Xiang Yang, Jiaying Lu, Mei Cui, Chuantao Zuo, Qiang Dong, Lan Tan et al. · 2020 · Journal of Alzheimer s Disease
PET and SPECT Imaging of Neurodegenerative Diseases
Alexander E. Drzezga, Gérard N. Bischof, Kathrin Giehl, Thilo van Eimeren · 2021 · Elsevier eBooks
A Physics-Informed Geometric Learning Model for Pathological Tau Spread in Alzheimer’s Disease
Tzu-An Song, Samadrita Roy Chowdhury, Fan Yang, Heidi I.L. Jacobs, Jorge Sepulcre, Van Jay Wedeen, Keith A. Johnson, Joyita Dutta · 2020 · Lecture notes in computer science
Predictive Value of Plasma Biomarkers in Tau‐ PET Transitions
Jonathan Graff‐Radford, Jeremy A. Syrjanen, Prashanthi Vemuri, Val J. Lowe, Christopher G. Schwarz, Heather J. Wiste, Walter K. Kremers, Alicia Algeciras‐Schimnich, Alexa Pichet Binette, Ruben A Smith et al. · 2025 · Annals of Neurology
Spatial patterns of tau accumulation across the Alzheimer's disease spectrum
Corrina S. Fonseca, Yishu Chao, Renaud La Joie, Gil Dan Rabinovici, William J. Jagust, Theresa M. Harrison, Alzheimer’s Disease Neuroimaging Initiative · 2026 · Alzheimer s & Dementia
Characterizing amyloid and tau positron emission tomography‐based stages across the clinical continuum
Karly Alex Cody, Andrzej Sokolowski, Emily Johns, Lucah Medina Guerra, Joseph R. Winer, Christina B. Young, Kyan Younes, Logan C. Dumitrescu, Derek B. Archer, Alaina Durant et al. · 2026 · Alzheimer s & Dementia
Joint EANM/SNMMI recommendations on the use of Tau PET imaging in Alzheimer's disease
Matthias Brendel, Phillip H. Kuo, Joachim Brumberg, Vincent Doré, Alexander E. Drzezga, Valentina Garibotto, Antoine Leuzy, Gregory Mathoux, Philipp Tobias Meyer, Alexis Moscoso et al. · 2026 · The EANM Journal
Analytical and clinical validation of the Lumipulse G plasma p‐tau217 assay for clinical implementation
Burak Arslan, Johan Gobom, Ulf Andréasson, Laia Montoliu‐Gaya, Andréa Lessa Benedet, Anna Dittrich, Silke Kern, Ingmar Gr. Skoog, Nicholas James Ashton, Tevy Chan et al. · 2026 · Alzheimer s & Dementia
Brain-First vs. Body-First Models in Neurodegenerative Disease: A Perspective Review
Giuseppe Forte, Maria Casagrande · 2026 · NeuroSci
Tau extent outperforms tau load as a predictor of neurodegeneration in Alzheimer’s disease
Arthur C. Macedo, Lydia Trudel, Seyyed Ali Hosseini, Joseph Therriault, Étienne Aumont, Gleb Bezgin, Nesrine Rahmouni, Jenna Stevenson, Cécile Tissot, Marcel S. Woo et al. · 2026 · Molecular Neurodegeneration
A lifespan staging model of basal forebrain cholinergic vulnerability
Hayley R. C. Shanks, Sherry Chen, Kate M. Onuska, Taylor W. Schmitz · 2026 · Alzheimer s & Dementia
A simple genetic stratification method for lower cost, more expedient clinical trials in early Alzheimer's disease: A preliminary study of tau PET and cognitive outcomes
Xin Wang, Iris Broce, Yuqi Qiu, Kacie Deters, Chun Chieh Fan, Anders Martin Dale, Steven D. Edland, Sarah Jane Banks, Alzheimer’s Disease Neuroimaging Initiative · 2023 · Alzheimer s & Dementia
Modulation of contextual fear acquisition and extinction by acute and chronic relaxin-3 receptor (RXFP3) activation in the rat retrosplenial cortex
Mónica Navarro-Sánchez, Isis Gil‐Miravet, Daniel Montero-Caballero, Ross A. D. Bathgate, Mohammed Akhter Hossain, Esther Castillo-Gómez, Andrew L. Gundlach, Francisco Eliseo Olucha-Bordonau · 2024 · Biochemical Pharmacology
The predictive role of olfactory identification on episodic memory and mild cognitive impairment: Results from the CIMA-Q cohort
Benoît Jobin, Natalie A. Phillips, Johannes Frasnelli, Benjamin Boller, The CIMA-Q group · 2025 · Journal of Alzheimer s Disease
Multi-Scale Temporal Imaging: From Micro- and Meso- to Macro-scale-time Nuclear Medicine
Faraz Farhadi, Jayasai R. Rajagopal, Eren M. Veziroglu, Hamid Abdollahi, Isaac Shiri, Moozhan Nikpanah, Michael A. Morris, Habib Zaidi, Arman Rahmim, Babak Saboury · 2022 · PET Clinics
Scan-Time Corrections for 80–100-min Standardizetd Uptake Volume Ratios to Measure the 18F-AV-1451 Tracer for Tau Imaging
Mark He, Suzanne L. Baker, Vyoma D. Shah, Samuel Neal Lockhart, William J. Jagust · 2018 · IEEE Transactions on Medical Imaging
Connectome-Mediated Prediction of Future Tau-PET Burden in Alzheimer’s Disease
Pablo F. Damasceno, Renaud La Joie, Sergey Shcherbinin, Sudeepti S. Southekal, Vikas Kotari, Ixavier A. Higgins, Emily C. Collins, Gil D. Rabinovici, Mark A Mintun, Ashish Raj · 2022 · Journal of Biotechnology and Biomedicine
Tau PET imaging evidence in patients with cognitive impairment: preparing for clinical use
Camille Noirot, Ismini Mainta, Aline Mendes, Paulina Andryszak, Hishayine Visvaratnam, Paul Gerson Unschuld, Giovanni Battista Frisoni, Valentina Garibotto · 2018 · Clinical and Translational Imaging
Induction and characterisation of Aβ and tau pathology in App NL-F/NL-F mice following inoculation with Alzheimer’s disease brain homogenate
Silvia A. Purro, Michael Farmer, Emma Quarterman, Julia Ravey, David X. Thomas, Elizabeth Noble, Catherine Turnbull, Jacqueline M. Linehan, Tamsin Nazari, Sebastian Brandner et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Development of a plasma biomarker diagnostic model as a screening strategy for Alzheimer's disease in older inpatients
Xiaoxia Fang, Zhengke Liu, Xiaojun Kuang, Xiushi Ni, Xu Han, Xuejun Wen, Hong Yan Xu · 2025 · Brain‐X
Integrating visual assessments and quantification methods for tau PET staging
Yuna Gu, Jihwan Yun, Alexis Moscoso, Michael Schöll, Daeun Shin, Eun Hye Lee, Heekyong Kang, Sohyun Yim, Hyunjin Jo, Jun Pyo Kim et al. · 2025 · Alzheimer s & Dementia
The study of plaques and tangles makes few and inaccurate predictions about the main features of cognitive disorders: A narrative review
Carlo Abbate, Alessia Gallucci · 2025 · Journal of Alzheimer s Disease
Neurobiological and neuroimaging biomarkers: A narrative review of precision medicine for diagnosing neurodegenerative disorders
Adeel Ahmed Abbasi, Farhat Jokhio, Farnaz Norouziyan, Nasrollah Moradikor · 2025 · NeuroMarkers.
Sex-specific patterns in tau spreading throughout the Braak stages in the Alzheimer’s disease spectrum
Xiwu Wang, Teng Ye, Bojian Dai, Jie Zhang, Wenjun Zhou, Alzheimer’s Disease Neuroimaging Initiative · 2026 · Journal of Alzheimer s Disease
Tau conformation, distribution and PET imaging correlations in progressive supranuclear palsy
Chong Dong, Jinghong Ma, Hongwen Qiao, Gilles D. Tamagnan, Piu Chan, Shuying Liu · 2026 · Translational Neurodegeneration
DTI-ALPS index and its association with neuroinflammatory and neurodegenerative biomarkers and tau-PET in Alzheimer’s continuum
Rasa Zafari, Amirhossein Kamroo, Tina Taherkhani, Fardin Nabizdeh, Mohammad Hadi Aarabi · 2026 · Neuroscience
Imaging biomarkers in neurodegenerative diseases: advances and challenges
Shreyasi Majumdar, Puneet Kumar Samaiya, Sahabuddi Ahmed, Santosh Kumar Prajapati · 2026 · Frontiers in Aging Neuroscience
A lipid-raft theory of Alzheimer's disease
Ari Rappoport · 2025 · Elsevier eBooks
Investigating the Association Between Verbal Forgetting and Pathological Markers of Alzheimer’s and Lewy Body Diseases
Morgan J. Schaeffer, Alzheimer’s Disease Neuroimaging Initiative, Brandy L. Callahan · 2019 · Journal of Alzheimer s Disease
Tau-PET Bildgebung der Demenzerkrankungen
Gérard N. Bischof · 2022 · Angewandte Nuklearmedizin
The mechanism and consequences of amyloid-β modulating thiamine pyrophosphokinase-1 expression in microglia
Xiaoqin Cheng, Ruoqi Zhao, Hongyan Qiu, Peiwen Song, Lanwen Kou, Shaoming Sang, Yingfeng Xia, Wenwen Cai, Boru Jin, Qiang Huang et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Functional Neuroimaging in Clinical Neurology: A Comprehensive Review of Commonly Used Modalities
Arash Salardini · 2025 · Seminars in Neurology
Biomarkers for Alzheimer's Disease
Deepak Panwar, Parul Sharma, Shweta Sharma, Manoj Malik, Jaspreet Kaur · 2024 · Advances in bioinformatics and biomedical engineering book series
Sex Differences in Alzheimer Disease-Related Biomarkers and Dementia Risk
Sima T Toopchiani, Anne Nyambura Njogu, Cynthia Smith, Shireen Sindi, Onah Okoye, Tamlyn Watermeyer, Chinedu Theresa Udeh‐Momoh · 2025 · Springer eBooks
Modifiable Factors Associated with the Longitudinal Increase and Spatial Extent of Tau Pathology in Alzheimer Disease
Merle C. Hoenig, Verena Dzialas, Elena Doering, Gérard N. Bischof, Thilo van Eimeren, Alexander E. Drzezga, Alzheimer’s Disease Neuroimaging Initiative · 2025 · Journal of Nuclear Medicine
Preclinical Alzheimer's and vascular biomarkers alter brain aging in cognitively normal adults: a MRI-based study
Unai Torres, David Bernal, Ibai Gurrutxaga, Ainara Estanga, Pablo Martínez‐Lage, Olatz Arbelaitz · 2025 · Frontiers in Aging Neuroscience
Neuro-Dynamic Quantitative Systems Pharmacology (QSP) model describing Alzheimer’s disease pathophysiology and treatment effects
Youfang Cao, Brian A. Willis, Kanta Horie, Kristin R. Wildsmith, Akihiko Koyama, Pallavi Sachdev, Natasha Penner, Arnaud Charil, Michael C. Irizarry, Larisa Reyderman · 2026 · npj Systems Biology and Applications
Amyloid spatial extent with florbetapir-PET for early detection of preclinical Alzheimer’s disease
Emma G. Thibault, Grace A Del Carmen Montenegro, John Alex Becker, Julie C. Price, Brian C. Healy, Bernard Jimmy Hanseeuw, Rachel F. Buckley, Heidi I.L. Jacobs, Michael J Properzi, Reisa Anne Sperling et al. · 2026 · The Journal of Prevention of Alzheimer s Disease
A unified deep learning framework for cross-platform harmonization of multi-tracer PET quantification in neurodegenerative disease
Jing Wang, Aocheng Zhong, Qian Xu, Haolin Huang, Y H Zhu, Jiaying Lu, Min Wang, Jiehui Jiang, Chengyang Li, Ming Ni et al. · 2026 · npj Digital Medicine
Exploring the Expression Changes of Immune Genes in Alzheimer's Disease: A Study on ANXA1, VCAM1, and CCL2
Fateme Fattahi, Samin Abed, Ghazal Kouchakali, Sima Mansoori Derakhshan, Reza Naghdi Sadeh, Mahmoud Shekari Khaniani · 2026 · Molecular Neurobiology
Low-dose CT for MRI-free quantification of tau PET in Alzheimer’s disease: a multicentre, cross-sectional, comparison study
Guilherme Povala, Lívia Amaral, Bruna Bellaver, Firoza Zubeida Lussier, Pâmela C.L. Ferreira, Douglas Teixeira Leffa, Guilherme Bauer‐Negrini, Raphael de Luca e Tuma, Álvaro de Oliveira Franco, Cécile Tissot et al. · 2026 · The Lancet Medical Imaging & Theranostics
Traits and Trammels of Tau Tracer Imaging
Victor L. Villemagne, Brian J. Lopresti, Vincent Doré, Davneet Singh Minhas, Alexandra Gogola, Neelesh K. Nadkarni, Neale Scott Mason, Pierrick Bourgeat, Oscar L. López, Miloš D. Ikonomović et al. · 2023 · Springer eBooks
Cognitive Aging and the Transition to Early Alzheimer’s Disease
Elizabeth C. Mormino, William J. Jagust · 2024 · Oxford University Press eBooks
Impact of the New Conceptual Framework of Alzheimer’s Disease in Imaging Studies
Bruno Dubois, Nicolas Villain, Claudia Jacova, Olga Uspenskaya · 2020 · Springer eBooks
The role of tau and neuroinflammation in Progressive Supranuclear Palsy and Alzheimer's Disease
Patricia Vázquez Rodríguez · 2019 · Apollo (University of Cambridge)
PET Biomarkers for Tau Pathology
Antoine Leuzy, Kerstin Heurling, Michael Schöll · 2019 · Springer eBooks
Spatial Registration Evaluation of [18F]-MK6240 PET
Zou, James, Aubrey S. Johnson, France, Jeanelle, Srinidhi Bharadwaj, Zeljko Tomljanovic, Yaakov Stern, Adam M. Brickman, Devangere Devanand, Jose Alejandro Luchsinger, William Charles Kreisl et al. · 2020 · arXiv (Cornell University)
A Multimodal Neuroimaging Approach for Classification and Prediction of Alzheimer's Disease Using Machine Learning
Parisa Forouzannezhad · 2020 · FIU - Digital Commons (Florida International University)
Longitudinal tau PET using [ 18 F]flortaucipir: Comparison of (semi)quantitative parameters
Denise Visser, Hayel Tuncel, Rik Ossenkoppele, Maqsood M. Yaqub, Emma E. Wolters, Tessa Timmers, Emma Weltings, Emma M. Coomans, Marijke E den Hollander, Wiesje M. van der Flier et al. · 2021 · medRxiv
Image-level trajectory inference of tau pathology using variational autoencoder for Flortaucipir PET
Jimin Hong, Seung Kwan Kang, Ian Alberts, Jiaying Lu, Raphael Sznitman, Jae Sung Lee, Axel Rominger, Hongyoon Choi, Kuangyu Shi · 2021 · Research Square
Polygenic effect on accelerated tau pathology accumulation in Alzheimer’s disease: implications for patient selection in clinical trials
Anna Rubinski, Simon Frerich, Rainer Malik, Nicolai Franzmeier, Alfredo Ramírez, Martin Dichgans, Michael Ewers, Alzheimer’s Disease Neuroimaging Initiative · 2021 · medRxiv
Faculty Opinions recommendation of Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer's disease.
John Wesson Ashford · 2018 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Principles of PET and Its Role in Understanding Drug Delivery to the Brain
Stina Syvänen, Roger N. Gunn, Lei Zhang · 2022 · AAPS advances in the pharmaceutical sciences series
Neuropharmacology in Alzheimer and Huntington Disease
Bandna Gupta, Kopal Rohatgi · 2022 · BENTHAM SCIENCE PUBLISHERS eBooks
Lateral flow assay for early diagnosis of neurodegenerative disorder
Tarun Kumar Kumawat, Arpana Parihar, Varsha Kumawat, Vishnu Lal Sharma, Anjali Pandit, Bhoomika Sharma, Manish Biyani · 2023 · Elsevier eBooks
The long distance relationship of regional amyloid burden and tau pathology spread
Merle C. Hoenig, Elena Doering, Gérard N. Bischof, Alexander E. Drzezga, Thilo van Eimeren, the Alzheimer’s Disease Neuroimaging Initiative · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
PET Biomarkers for Tau Pathology
Antoine Leuzy, Kerstin Heurling, Michael Schöll · 2024 · Springer eBooks
The Intrinsic Connectivity between the Default Mode and Dorsal Attention Networks Is a Marker of Alzheimer's Pathology Burden Independent of Cognitive Reserve
Diego Lombardo, Christian F. Beckmann · 2024 · SSRN Electronic Journal
[Erratum] Brain Imaging and neurostimulation in health and disorders: status report
Abrahão Fontes Baptista, Adenauer Girardi Casali, Adriana Leico Oda, Alexandre Hideki Okano, Alexandre Moreira, Ana Lúcia Yaeko da Silva Santos, Ana Mércia Fernandes, Ana Paula Fontana, André R. Brunoni, André Ricardo Oliveira Fonseca et al. · 2024 · Brain Imaging and Stimulation
New Research on Biomarkers in Alzheimer’s Continuum
Immacolata Vecchio, Carmela Colica · 2025 · Reviews on Recent Clinical Trials
Vascular β-amyloid potentially colocalises with phosphorylated tau in cerebral amyloid angiopathy
Hsin-hsi C Tsai, Bo‐Ching Lee, Chia‐Ju Liu, Pu‐Tien Chiang, Ya-Chin Tsai, Li‐Kai Tsai, Syu‐Jyun Peng · 2025 · Stroke and Vascular Neurology